C12N 9/0073
With nadh or nadph as one donor, and incorporation of one atom
Official title: {with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13}
C12N9/0073 (With nadh or nadph as one donor, and incorporation of one atom) appears on 406 US grants and 544 published applications in this corpus.
Search patents in C12N- Granted patents
- 406
- Published applications
- 544
- Assignees
- 312
- Inventors
- 1,215
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 12 | 0 |
| 1998 | 15 | 0 |
| 1999 | 12 | 0 |
| 2000 | 9 | 0 |
| 2001 | 11 | 0 |
| 2002 | 4 | 16 |
| 2003 | 9 | 15 |
| 2004 | 8 | 11 |
| 2005 | 5 | 12 |
| 2006 | 4 | 13 |
| 2007 | 8 | 10 |
| 2008 | 7 | 8 |
| 2009 | 7 | 12 |
| 2010 | 4 | 22 |
| 2011 | 11 | 15 |
| 2012 | 10 | 13 |
| 2013 | 9 | 19 |
| 2014 | 9 | 20 |
| 2015 | 14 | 30 |
| 2016 | 21 | 31 |
| 2017 | 16 | 32 |
| 2018 | 17 | 25 |
| 2019 | 29 | 31 |
| 2020 | 28 | 34 |
| 2021 | 22 | 31 |
| 2022 | 14 | 42 |
| 2023 | 19 | 25 |
| 2024 | 20 | 35 |
| 2025 | 21 | 24 |
| 2026 | 10 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- RNA preparations comprising purified modified RNA for reprogramming cells16 Jun 2026US 12,655,395 B2
- Conversion of lignin-derived monomers to muconate by engineered pseudomonas21 Apr 2026US 12,606,852 B2Alliance for Energy Innovation, LLC
- Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways24 Mar 2026US 12,582,709 B2The Regents of the University of California
- Transgenic microorganisms and synthesis of piperazic acid, piperazic acid containing products, and derivatives thereof17 Mar 2026US 12,577,597 B2Washington University
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
- Abc transporters for the high efficiency production of rebaudiosides3 Sep 2026US 2026/0258467 A1Amyris, Inc.
- Compositions and methods for the treatment of sepsis13 Aug 2026US 2026/0234635 A1
- Test system comprising stably cyp-transfected or transduced mammalian cells6 Aug 2026US 2026/0226427 A1Brandenburgische Technische Universität Cottbus-Senftenberg
- Alternative strategies for methanobactin production16 Jul 2026US 2026/0201319 A1Iowa State University Research Foundation, Inc.
Most cited
By later US patents
- AAV-mediated delivery of DNA to cells of the nervous system222US 6,180,613 B2The Rockefeller University · 2001
- Compositions and methods of altering cholesterol levels149US 8,980,864 B2Moderna Therapeutics, Inc. · 2015
- Methods for promoting wound healing and treating transplant-associated vasculopathy133US 5,830,461 AUniversity of Pittsburgh—Of the Commonwealth System of Higher Education · 1998
- Methods for promoting wound healing and treating transplant-associated vasculopathy131US 6,103,230 AUniversity of Pittsburgh—Of the Commonwealth System of Higher Education · 2000
- Enhancement of vascular function by modulation of endogenous nitric oxide production or activity126US 5,891,459 AThe Board of Trustees of the Leland Stanford Junior University · 1999